Evolution of Immunosuppressive Agents in Renal Transplantation: An Updated Review
Journal Title: International Journal of Stem Cell Research and Transplantation (IJST) - Year 2016, Vol 4, Issue 3
Abstract
Suppression of allograft rejection is the central issue in renal transplantation (RT). Thus, development of immunosuppressive agents is the key for successful allograft function. Immunosuppression agents in RT have evolved over the last six decades beginning with total lymphoid irradiation to the currently available immunosuppressive strategies, which have significantly reduced the incidence of acute rejection episodes and improved short-term graft and patient outcomes. However their use is associated with long-term graft dysfunction, hypertension, hyperlipidaemia, diabetes mellitus, infections and malignancies. Chronic antibody-mediated rejection and chronic allograft dysfunction still remain the major problems, often leading to graft loss and shortened long-term graft survival. Immunosuppressive agents are used for induction, maintenance and reversal of established rejection. The use of multidrug regimen tailored to the immunological risk of patient and adverse-effect profile of the drug provides the optimum outcomes.This review focuses on the evolution of immunosuppression agents used in RT over last six decades and highlights the newer agents under investigation.
Authors and Affiliations
Badri Shrestha
Keywords
Related Articles
- EP ID EP198001
- DOI 10.19070/2328-3548-1600027
- Views 101
- Downloads 0
Search for Chemically Defined Culture Medium to Assist Initial Regeneration of Diseased Renal Parenchyma After Stem/Progenitor Cell Implantation
Before an intended implantation stem/progenitor cells are usually kept in the beneficial atmosphere of a selected culture medium. However, after implantation the situation is drastically changing for them. Yet stem/proge...
Improved Differentiation of Mesenchymal Stem Cells into Hepatocyte-like Cells using FGF4 and IGF-1 in 3D Culture
Human Umbilical Cord Mesenchymal Stem Cells (UCMSCs) are considered as an excellent candidate for cell therapy to treat end-stage liver disease. Fibroblast Growth Factor-4 (FGF4), Hepatocyte Growth Factor, and Insulin-li...
Renal Transplantation from Donation After Circulatory Death Donors: Evolution of Strategies
Renal Transplantation from Donation After Circulatory Death Donors: Evolution of Strategies
Epigenetic Regulation of Retinal Stem Cells
Epigenetic Regulation of Retinal Stem Cells
Human Umbilical Cord Matrix - Derived Stem Cells Show Tropism Towards the Human Glioma Microenvironment
Objective: Glioblastoma multiforme (GBM) is an aggressive type of brain tumor in humans. The median survival of patients is a year after diagnosis. It is a great challenge to identify new therapeutic strategies that coul...